These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27506746)

  • 1. Validation of a metabolite panel for early diagnosis of type 2 diabetes.
    Carter TC; Rein D; Padberg I; Peter E; Rennefahrt U; David DE; McManus V; Stefanski E; Martin S; Schatz P; Schrodi SJ
    Metabolism; 2016 Sep; 65(9):1399-408. PubMed ID: 27506746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood microRNA-15a is a potential biomarker for type 2 diabetes mellitus and pre-diabetes.
    Al-Kafaji G; Al-Mahroos G; Alsayed NA; Hasan ZA; Nawaz S; Bakhiet M
    Mol Med Rep; 2015 Nov; 12(5):7485-90. PubMed ID: 26460159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers for predicting type 2 diabetes development-Can metabolomics improve on existing biomarkers?
    Savolainen O; Fagerberg B; Vendelbo Lind M; Sandberg AS; Ross AB; Bergström G
    PLoS One; 2017; 12(7):e0177738. PubMed ID: 28692646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort.
    Silvestre MP; Jiang Y; Volkova K; Chisholm H; Lee W; Poppitt SD
    Prim Care Diabetes; 2017 Dec; 11(6):561-569. PubMed ID: 28801192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a model for predicting incident type 2 diabetes using quantitative clinical data and a Bayesian logistic model: A nationwide cohort and modeling study.
    Wilkinson L; Yi N; Mehta T; Judd S; Garvey WT
    PLoS Med; 2020 Aug; 17(8):e1003232. PubMed ID: 32764746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults.
    Qiu G; Zheng Y; Wang H; Sun J; Ma H; Xiao Y; Li Y; Yuan Y; Yang H; Li X; Min X; Zhang C; Xu C; Jiang Y; Zhang X; He M; Yang M; Hu Z; Tang H; Shen H; Hu FB; Pan A; Wu T
    Int J Epidemiol; 2016 Oct; 45(5):1507-1516. PubMed ID: 27694567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early metabolic markers identify potential targets for the prevention of type 2 diabetes.
    Peddinti G; Cobb J; Yengo L; Froguel P; Kravić J; Balkau B; Tuomi T; Aittokallio T; Groop L
    Diabetologia; 2017 Sep; 60(9):1740-1750. PubMed ID: 28597074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma metabolites associated with type 2 diabetes in a Swedish population: a case-control study nested in a prospective cohort.
    Shi L; Brunius C; Lehtonen M; Auriola S; Bergdahl IA; Rolandsson O; Hanhineva K; Landberg R
    Diabetologia; 2018 Apr; 61(4):849-861. PubMed ID: 29349498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for early diagnosis of type 2 diabetic nephropathy: a study based on an integrated biomarker system.
    Huang M; Liang Q; Li P; Xia J; Wang Y; Hu P; Jiang Z; He Y; Pang L; Han L; Wang Y; Luo G
    Mol Biosyst; 2013 Aug; 9(8):2134-41. PubMed ID: 23719966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of liver enzyme levels as predictive markers of glucose metabolism disorders in a Tunisian population.
    Bouhajja H; Abdelhedi R; Amouri A; Hadj Kacem F; Marrakchi R; Safi W; Mrabet H; Chtourou L; Charfi N; Fourati M; Bensassi S; Jamoussi K; Abid M; Ayadi H; Mnif-Feki M; Bougacha-Elleuch N
    Can J Physiol Pharmacol; 2018 Nov; 96(11):1171-1180. PubMed ID: 29527933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The product of triglycerides and glucose in comparison with fasting plasma glucose did not improve diabetes prediction.
    Janghorbani M; Almasi SZ; Amini M
    Acta Diabetol; 2015 Aug; 52(4):781-8. PubMed ID: 25572334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach.
    Menni C; Fauman E; Erte I; Perry JR; Kastenmüller G; Shin SY; Petersen AK; Hyde C; Psatha M; Ward KJ; Yuan W; Milburn M; Palmer CN; Frayling TM; Trimmer J; Bell JT; Gieger C; Mohney RP; Brosnan MJ; Suhre K; Soranzo N; Spector TD
    Diabetes; 2013 Dec; 62(12):4270-6. PubMed ID: 23884885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive 13C-glucose breath test using residual gas analyzer-mass spectrometry: a novel tool for screening individuals with pre-diabetes and type 2 diabetes.
    Ghosh C; Maity A; Banik GD; Som S; Chakraborty A; Selvan C; Ghosh S; Ghosh B; Chowdhury S; Pradhan M
    J Breath Res; 2014 Sep; 8(3):036001. PubMed ID: 24946152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal metabolite and protein trajectories prior to diabetes mellitus diagnosis in Danish blood donors: a nested case-control study.
    Lundgaard AT; Westergaard D; Röder T; Burgdorf KS; Larsen MH; Schwinn M; Thørner LW; Sørensen E; ; Nielsen KR; Hjalgrim H; Erikstrup C; Kjerulff BD; Hindhede L; Hansen TF; Nyegaard M; Birney E; Stefansson H; Stefánsson K; Pedersen OBV; Ostrowski SR; Rossing P; Ullum H; Mortensen LH; Vistisen D; Banasik K; Brunak S
    Diabetologia; 2024 Oct; 67(10):2289-2303. PubMed ID: 39078488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-sectional study of the determinants and associations of sex hormone-binding globulin concentrations in first degree relatives (FDR) of patients with Type 2 Diabetes Mellitus.
    Abdella NA; Mojiminiyi OA
    Diabetes Res Clin Pract; 2017 Nov; 133():159-167. PubMed ID: 28950181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and plasma amino acids as markers of prediabetes, insulin resistance, and incident diabetes.
    Gar C; Rottenkolber M; Prehn C; Adamski J; Seissler J; Lechner A
    Crit Rev Clin Lab Sci; 2018 Jan; 55(1):21-32. PubMed ID: 29239245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls.
    Canivell S; Rebuffat S; Ruano EG; Kostov B; Sisó-Almirall A; Novials A; Ceriello A; Gomis R
    Diabetes Metab Res Rev; 2015 Feb; 31(2):212-9. PubMed ID: 25139699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Plasma Metabolome Profiles Following Oral Glucose Challenge among Adult Chinese.
    Huo S; Sun L; Zong G; Shen X; Zheng H; Jin Q; Li H; Yin H; Lin X
    Nutrients; 2021 Apr; 13(5):. PubMed ID: 33925473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Area under the curve during OGTT in first-degree relatives of diabetic patients as an efficient indicator of future risk of type 2 diabetes and prediabetes.
    Feizi A; Meamar R; Eslamian M; Amini M; Nasri M; Iraj B
    Clin Endocrinol (Oxf); 2017 Dec; 87(6):696-705. PubMed ID: 28793372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The product of fasting plasma glucose and triglycerides improves risk prediction of type 2 diabetes in middle-aged Koreans.
    Lee JW; Lim NK; Park HY
    BMC Endocr Disord; 2018 May; 18(1):33. PubMed ID: 29843706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.